Fig. 6From: Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapyMerTK ASO causes no retinal toxicity. Eyes from mice were harvested on day 21 and stained with H&E and toluidine blueBack to article page